Macrocyclic Therapeutics
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
220
NCT06577987
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 14, 2024
Completion: Mar 14, 2027
Loading map...